deferoxamine has been researched along with palmitic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SE; Han, SJ; Jung, IR; Jung, JG; Kang, Y; Kim, DJ; Kim, HJ; Lee, KW; Lee, SA | 1 |
Choi, SE; Cui, R; Jeon, JY; Kang, Y; Kim, HJ; Kim, TH; Lee, HJ; Lee, KW; Lee, SJ | 1 |
2 other study(ies) available for deferoxamine and palmitic acid
Article | Year |
---|---|
Involvement of iron depletion in palmitate-induced lipotoxicity of beta cells.
Topics: Animals; Apoferritins; Benzoates; Cell Death; Cell Line, Tumor; Chlorides; Deferasirox; Deferoxamine; eIF-2 Kinase; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Ferric Compounds; Ferrous Compounds; Gene Expression Regulation; Humans; Insulin-Secreting Cells; Iron Chelating Agents; Iron Deficiencies; JNK Mitogen-Activated Protein Kinases; Palmitic Acid; Rats; Receptors, Transferrin; Signal Transduction; Transcription Factor CHOP; Transferrin; Triazoles | 2015 |
Iron overload by transferrin receptor protein 1 regulation plays an important role in palmitate-induced insulin resistance in human skeletal muscle cells.
Topics: Adult; Animals; Antigens, CD; Case-Control Studies; Cells, Cultured; Deferoxamine; Diabetes Mellitus, Type 2; Enzyme Activation; Gene Knockdown Techniques; Humans; Insulin Resistance; Iron Chelating Agents; Iron Overload; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Middle Aged; Muscle, Skeletal; Palmitic Acid; Receptors, Transferrin | 2019 |